Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01931033 · ClinicalTrials.gov registry record · NA
An Open-Label Trial of Oxytocin in Adolescents With Autism Spectrum Disorders
A NA study of Autism Spectrum Disorders and ASD, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT01931033 is a NA study of Autism Spectrum Disorders and ASD that has completed, run by Massachusetts General Hospital. The registered enrollment target is 8 participants, below the 168-participant average among 20 other Autism Spectrum Disorders trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01931033, a NA study of Autism Spectrum Disorders and ASD, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is an 8-week open-label trial testing oxytocin nasal spray (Syntocinon) as a treatment for social impairment in adolescents with autism spectrum disorders (ASD). We hypothesize that oxytocin nasal spray will be safe, tolerable, and effective in improving the core symptoms of autism spectrum disorders in adolescents ages 11-17.
Conditions Studied
Interventions
- DRUG Intranasal Oxytocin
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2013-10 |
| Est. Completion | 2016-02-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01931033
The ClinicalTrials.gov registry entry for NCT01931033 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 168-participant average among 20 other Autism Spectrum Disorders trials with a reported enrollment target (95% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Autism Spectrum Disorders appearing as the primary indexed condition, and to 1 intervention - of which Intranasal Oxytocin is the first listed.
NCT01931033 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01931033 about?
NCT01931033 is a clinical study titled "An Open-Label Trial of Oxytocin in Adolescents With Autism Spectrum Disorders". This study is an 8-week open-label trial testing oxytocin nasal spray (Syntocinon) as a treatment for social impairment in adolescents with autism spectrum disorders (ASD). We hypothesize that oxytocin nasal spray will be safe, tolerable, and effective in improving the core symptoms of autism spectr...
What is the current status of trial NCT01931033?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2013-10. Estimated completion is 2016-02-22.
What conditions does trial NCT01931033 study?
This clinical trial studies the following conditions: Autism Spectrum Disorders, ASD, PDD, Pervasive Developmental Disorders.
What interventions are being tested in trial NCT01931033?
The interventions under investigation include: Intranasal Oxytocin (DRUG).
Who is sponsoring clinical trial NCT01931033?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01931033 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism Spectrum Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Water Competency Intervention in Autism
RECRUITING · NA
-
Project AFECT (Autism Family Empowerment Coaching and Training Program)
ACTIVE NOT RECRUITING · NA
-
Telehealth Coaching for Families of Children With Autism
COMPLETED · NA
-
Screening and Linkage to Services for Autism
COMPLETED · NA
-
Virtual Reality Social Cognition Training for Adults With Autism Spectrum Disorders
COMPLETED · NA
-
Pivotal Response Treatment for Children With Autism Spectrum Disorders
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.